Skip to record
ExecutivesJill M. Broadfoot

Executive record

Jill M. Broadfoot

Public governance roles and source-backed Claims for this individual.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:jill-m-broadfoot-atyrVersion: public-0As of: 2026-09-30

Not yet claimed8 published Claims2 sources

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims8Within this recordEvidence sources2Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Ms. Broadfoot has served as CFO of aTYR Pharma since July 2018, previously serving as CFO of Emerald Health Pharmaceuticals, VP U.S. Corporate Controller at GW Pharmaceuticals, and CFO of Vical Inc. She holds a B.S. in business administration and accounting from San Diego State University and is a Certified Public Accountant.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.